Colchero MA, Cortés-Ortiz MA, Romero-Martínez M, Vega H, González A, Román R, Franco-Núñez A, Bautista-Arredondo S

Language: English
References: 17
Page: 99-106
PDF size: 243.87 Kb.

ABSTRACT

Objective. To present results from HIV testing, knowledge of HIV status and socioeconomic factors associated with the probability of having a HIV positive result among transwomen (TW) in Mexico. Materials and methods. In 2012, we conducted an HIV seroprevalence survey to 585 TW in Mexico City in three strata: gathering places, the Condesa HIV Clinic and in four detention centers. We estimated the prevalence of HIV in each strata and applied a probit model to the overall sample to analyze factors associated with the probability of a HIV positive result. Results. The prevalence of HIV was 19.8% in meeting places; 31.9% in detention centers and 64% among the participants of the clinic. Age, low education and number of sexual partners was positively associated with HIV. Conclusions. Results from the study provide relevant information to design HIV prevention interventions tailored to the needs of the TW population.

REFERENCES

1. World Health Organization. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recomendations for a public approach. Geneva: WHO Department of HIV/AIDS, 2011.

2. Boyce S, Barrington C, Bolanos H, Arandi CG, Paz-Bailey G. Facilitating access to sexual health services for men who have sex with men and male-to-female transgender persons in Guatemala City. Cult Health Sex 2012;14(3):313-327.

3. Ramirez-Valles J, Garcia D, Campbell RT, Diaz RM, Heckathorn DD. HIV infection, sexual risk behavior, and substance use among Latino gay and bisexual men and transgender persons. Am J Public Health 2008;98(6):1036-1042.

4. Nuttbrock L, Bockting W, Rosenblum A, Hwahng S, Mason M, Macri M, et al. Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study. Am J Public Health 2013;103(2):300-307.

5. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013;13(3):214-222.

6. Centro Nacional para la Prevención y Control del VIH/sida. El VIH/sida en México. México: Censida, 2009.

7. Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa- Rubi SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PloS One 2013;8(9):e72616.

8. Comisión de Derechos Humanos. Informe que presenta la Comisión de Derechos Humanos del Distrito Federal con motivo de la visita del relator sobre derechos humanos de las personas privadas de libertad. Distrito Federal: CDHDF, 2011.

9. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, et al. Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Intl J Methods Psychiatr Res 2004;13(2):122-139.

10. Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc) 1995;104(20):771-776.

11. Weir SS, Pailman C, Mahlalela X, Coetzee N, Meidany F, Boerma JT. From people to places: focusing AIDS prevention efforts where it matters most. Aids 2003;17(6):895-903.

12. Trinity Biotech. Uni-Gold Recombigen HIV-1/2. Ref 1206506 [accessed on December 2014]. Available at: http://www.trinitybiotech.com/Product% 20Documents/1206506-29%20EN.pdf

13. Sanchez T, Finlayson T, Murrill C, Guilin V, Dean L. Risk behaviors and psychosocial stressors in the new york city house ball community: a comparison of men and transgender women who have sex with men. AIDS Behav 2010;14(2):351-358.

14. Clements-Nolle K, Marx R, Guzman R, Katz M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health 2001;91(6):915-921.

15. Silva-Santisteban A, Raymond HF, Salazar X, Villayzan J, Leon S, McFarland W, et al. Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: results from a sero-epidemiologic study using respondent driven sampling. AIDS Behav 2012;16(4):872-881.

16. Colchero MA, Cortés MA, Sosa-Rubi SG, Bautista-Arredondo S, Vega H, Rodriguez V, et al. Resultados de la Encuesta de salud con seroprevalencia de VIH a mujeres transgénero en la Ciudad de México. México: INSP, 2013.

17. Crabtree-Ramirez B, Caro-Vega Y, Belaunzaran-Zamudio F, Sierra- Madero J. High prevalence of late diagnosis of HIV in Mexico during the HAART era. Salud Publica Mex 2012;54(5):506-514.